Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02924883 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based Therapy (KATE2) |
| First Submitted : | September 21, 2016 |
| First Submitted that Met QC Criteria : | October 4, 2016 |
| First Posted : | October 5, 2016 (Estimate) |
| Results First Submitted : | December 9, 2018 |
| Results First Submitted that Met QC Criteria : | January 23, 2019 |
| Results First Posted : | February 12, 2019 |
| Last Update Submitted that Met QC Criteria : | January 28, 2021 |
| Last Update Posted : | February 17, 2021 |